The Asia Pacific Surgical Equipment Market Size was valued at USD 7.19 Billion in 2023. The Global Asia Pacific Surgical Equipment industry is projected to grow from USD 7.58 Billion in 2024 to USD 13.4 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.67% during the forecast period (2024 - 2032). Surgical equipment plays a vital role during the surgeries. It is one of the important aspects in the medical as well as medical technology. With the developing surgical procedure, the trade of the instrument is developing.
The instrument must have good quality and elaborative ornament to be prefer widely. Surgical equipment are widely used in neurosurgery, wound closure, urology, cardiovascular surgeries, orthopedic surgery, and others.Â
In July 2023, Smith+Nephew has launched REGENETEN Bioinductive Implant in India for rotator cuff injury treatment.
In May 2023, The first procedures were performed through Stryker’s Q Guidance System with Cranial Guidance Software as directed by surgeons
In May 2023, Smith+Nephew utilizes robotics for customized surgeries supported by an AI-based planning application and data visualization platform.
In June 2023, BD Unveils Their New Robotic System for Automating Clinical Flow Cytometry.
In September 2022, Olympus Corporation, a MedTech company, has introduced THUNDERBEAT Open Fine Jaw Type X surgical energy devices for open surgery. THUNDERBEAT Open Fine Jaw Type X surgical energy device was reconstructed with the new thermal shield to improve safety during procedures. It is available commercially in Japan.
In September 2022, The Japanese firm Olympus Corporation unveiled its latest surgical visualization platform, VISERA ELITE III designed to cater to the needs of HCPs across multiple medical disciplines performing endoscopic procedures.
In February 2022, Smith+Nephew also announced the release of the CORI Surgical System, their next-generation handheld robotic platform in Japan. Smith+Nephew’s NAVIO Surgical System has gained traction and proven itself over time in Japan as demonstrated by the growing use of its CORI Surgical System.
Also, Bengaluru’s Futura Surgicare Pvt Ltd expanded into a new vertical, Dolphin Hemostats and introduced Hemostax (Oxidised Regenerated Cellulose) under the brand Hemostax in February 2022. An absorbable hemostat known as the Hemostax Standard is expected to optimize surgeons’ control of bleeding rates. Such increased product launches in India promote market growth over the forecast period.Ethicon from Johnson & Johnson MedTech launched the ECHELON 3000 Stapler in June (part of Ethicon, Johnson & Johnson MedTech).
It is a digitally enabled device featuring enhanced one-handed powered articulation for unique patient requirements.In April 2022, Ethicon (part of Johnson & Johnson MedTech) launched the ENSEAL X1 Straight Jaw Tissue Sealer. This new, advanced bipolar energy device has improved cutting and transection functionality, more robust sealing and increased tissue capture per bite.
Increasing prevalence of chronic diseases, increasing number of hospitals, increasing geriatric population, and increasing healthcare expenditure boost the market growth. According to the World Health Organization (WHO), 60% of the world’s total diabetic population is living in Asia Pacific region. Additionally, diabetes is one of the major cause for cardiovascular diseases, which in turn, result into increased cardiac surgeries. Moreover, development in technology and increased government initiatives have a fuelled the growth of the market, from the last few years.
On the other hand, high cost of the devices, and shortage of skilled labor may slow the growth of the market.
The Asia Pacific surgical equipment market is expected to grow at a CAGR of 4.67% over forecasted period.
Asia Pacific surgical equipment market is into product type, application, and end users.
On the basis of product type the market is segmented into surgical sutures & staplers, handheld instruments, electrosurgical devices, electrosurgical generators, monitoring devices, and others. Surgical sutures & staplers are further segmented into absorbable and non-absorbable sutures. The handheld instruments are sub-segmented into forceps, sutures, visual scope, and others. The electrosurgical devices are further categorized into electrosurgical instruments (HET bipolar system, electrosurgical pencils, smoke evacuation system, and other), and electrosurgical generators.
On the basis of application, the market is segmented into neurosurgery, wound closure, urology, cardiovascular surgeries, orthopedic surgery, and others.
On the basis of end user, the market is segmented into government hospitals, private hospital, and other.
Asia Pacific surgical equipment market is segmented into Japan, China, India, Republic of Korea, Australia, and Rest of Asia Pacific. Increasing number of hospitals, rising geriatric population, and increasing healthcare expenditure drives the growth of Asia Pacific surgical equipment market. Moreover, increasing prevalence of chronic diseases, government initiatives, and increasing patient inflow have fuel the market growth. China holds the major share in the Asia Pacific surgical equipment market owing to huge geriatric population and rapidly developing economy. Moreover, India and Australia contributes considerable share to the market.
Key PlayersÂ
Some of the key players in this market:Â
 Intended Audience
| Attribute/Metric | Details |
| Market Size 2032 | Â USD 13.4 Billion by 2032 |
| CAGR | Â 4.67% (2024-2032) |
| Base Year | Â Â 2023 |
| Forecast Period | Â Â 2024-2032 |
| Historical Data | Â Â 2021 |
| Forecast Units | Â Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product Types, Application, End user |
| Geographies Covered | Asia Pacific |
| Countries Covered | Japan, China, India, Republic of Korea, Australia, and Rest of Asia Pacific |
| Key Vendors | Integra LifeSciences Corporation (US), Boston Scientific Corporation (US), Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Ethicon LLC. (US), Stryker Corporation (US), COVIDIEN (US), CONMED Corporation (US), MEDICON (US), Synergetics USA, Inc. (US), Erbe Elektromedizin GmbH (Germany), KARL STORZ & Co. (US), KLS Martin (Germany) |
| Key Market Opportunities | Increasing prevalence of chronic diseases Increasing number of hospitals |
| Key Market Dynamics | Increasing geriatric population, and increasing healthcare expenditure boost the market growth |
Asia Pacific Surgical Equipment Market Highlights:
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
